The Chronicle of Philanthropy

Gates Grant Seeks Vaccine for Pneumonia

The Bill & Melinda Gates Foundation plans to spend $75-million over five years to develop a vaccine to prevent the spread of pneumonia.

The money will support efforts by Path, a nonprofit group in Seattle, to work with pharmaceutical and biotechnology companies to develop a vaccine that targets several strains of pneumococcus, the bacterium...

To continue reading this Premium article, you must have a Chronicle account AND a subscription or online pass.

Subscriptions start at $42.50 for 12 issues; a 24-hour Web pass for under $10.

 

Subscribe | About The Chronicle | Contact us | Terms of use | Privacy policy | Help